On 27 January, Gilead Sciences Inc. (NASDAQ:GILD) said that it has signed an agreement with pharmacy-benefits manager EnvisionRx for an exclusive coverage of its hepatitis C drugs. On Monday shares of Gilead Sciences Inc. (NASDAQ:GILD) closed at $106.19. Company’s sales growth for last 5 years was 16.00% and EPS growth for next 5 years is recorded as 33.42%.
Chevron Corporation (NYSE:CVX) announced a $ 35 billion capital and exploratory investment program for 2015 on Friday. The investment plan is 13 percent lower than the total investments for 2014. Chevron Corporation (NYSE:CVX) in last trading activity advanced 3.44% to close at $106.06. Company weekly performance is -2.59% while its quarterly performance stands at -8.66%. Chevron Corporation (NYSE:CVX) is -20.09% away from its 52 week high.
On 31 January, Tesla Motors Inc (NASDAQ:TSLA) unveiled an all-wheel-drive version of its popular Model S. With dual motors in tow, the new Tesla P85D version of the Model S can accelerate from 0 to 60 miles per hour in just 3.2 seconds. On last trading day Tesla Motors Inc (NASDAQ:TSLA) advanced 3.61% to close at $210.94. Its volatility for the week is 3.52% while volatility for the month is 3.55%. TSLA’s sales growth for past 5 years was 167.50% and its EPS growth for past 5 years was 45.10%. Tesla Motors Inc (NASDAQ:TSLA) monthly performance is -5.16%.
UQM Technologies Inc. (NYSEMKT: UQM) said that it has been granted a U.S. patent for its electric and hybrid electric vehicle motor design using non-rare earth magnets. UQM Technologies Inc. (NYSEMKT: UQM) has 2.70% insider ownership while its institutional ownership stands at 17.20%. In last trading activity company’s stock closed at $0.97.
On 21 January, Versartis, Inc. (NASDAQ:VSAR) announced the pricing of an underwritten public offering of 4,347,826 shares of its common stock at a price to the public of $17.25 per share. In addition, Versartis has granted the underwriters a 30-day option to purchase up to 652,173 additional shares of common stock. On last trading day Versartis, Inc. (NASDAQ:VSAR) decreased -1.64% to close at $17.44. Its volatility for the week is 4.29% while volatility for the month is 6.74%. Versartis, Inc. (NASDAQ:VSAR) monthly performance is -22.32%.